|
AGPAT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77759999997473E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.19800000037063E-07 |
| Normal-vs-Stage2 |
2.302600E-03 |
| Normal-vs-Stage3 |
7.200200E-02 |
| Normal-vs-Stage4 |
5.968100E-02 |
| Stage1-vs-Stage2 |
4.388600E-01 |
| Stage1-vs-Stage3 |
9.312500E-02 |
| Stage1-vs-Stage4 |
1.091810E-01 |
| Stage2-vs-Stage3 |
7.882300E-02 |
| Stage2-vs-Stage4 |
1.017790E-01 |
| Stage3-vs-Stage4 |
9.335600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.41099999976191E-07 |
| Normal-vs-AfricanAmerican |
2.895600E-01 |
| Normal-vs-Asian |
6.561800E-01 |
| Caucasian-vs-AfricanAmerican |
2.877900E-02 |
| Caucasian-vs-Asian |
5.142400E-01 |
| AfricanAmerican-vs-Asian |
9.736400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45670000009746E-07 |
| Normal-vs-Female |
1.496010E-02 |
| Male-vs-Female |
3.663900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.481800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.20749999952008E-07 |
| Normal-vs-Age(61-80Yrs) |
1.979960E-03 |
| Normal-vs-Age(81-100Yrs) |
1.204360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.492600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.538800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.428800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.884100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.707800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.011600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.140400E-03 |
| Normal-vs-Grade 2 |
2.38460000001606E-06 |
| Normal-vs-Grade 3 |
1.210070E-04 |
| Normal-vs-Grade 4 |
8.864000E-01 |
| Grade 1-vs-Grade 2 |
9.970500E-02 |
| Grade 1-vs-Grade 3 |
1.277800E-02 |
| Grade 1-vs-Grade 4 |
2.055400E-03 |
| Grade 2-vs-Grade 3 |
2.561600E-01 |
| Grade 2-vs-Grade 4 |
3.816600E-03 |
| Grade 3-vs-Grade 4 |
1.138370E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.1448997305763E-10 |
| Normal-vs-ccB subtype |
3.561900E-02 |
| ccA subtype-vs-ccB subtype |
4.175700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.248540E-04 |
| Normal-vs-N1 |
9.244800E-01 |
| N0-vs-N1 |
2.319400E-01 |
|
|
